ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

GLYC GlycoMimetics Inc

1,8399
0,1199 (6,97%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,1199 6,97% 1,8399 06:00:05
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,67 1,63 1,84 1,83 1,72
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202413:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
27.3.202412:00BWGlycoMimetics Reports Highlights and Financial Results for..
13.3.202412:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
01.3.202415:16EDGAR2Form 8-K - Current report
26.2.202413:00BWGlycoMimetics to Participate in Upcoming Cowen 44th Annual..
12.2.202413:00BWGlycoMimetics Reports Inducement Grant Under NASDAQ Listing..
17.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202413:00BWGlycoMimetics Announces Positive Initial Safety and..
03.1.202413:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
02.1.202422:30EDGAR2Form 8-K - Current report
02.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.12.202318:00BWGlycoMimetics Announces Independent Presentations on..
09.11.202313:00BWGlycoMimetics to Participate in Upcoming Jefferies London..
03.11.202313:35EDGAR2Form 8-K - Current report
03.11.202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202312:00BWGlycoMimetics Reports Highlights and Financial Results for..
23.10.202314:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
20.10.202313:00BWGlycoMimetics to Report Third Quarter 2023 Financial Results..
03.10.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.9.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202313:00BWGlycoMimetics Announces First Cohort Dosed in Human Phase 1a..
05.9.202313:00BWGlycoMimetics to Participate in Upcoming H.C. Wainwright..
17.8.202313:00BWGlycoMimetics Reports Inducement Grant Under Nasdaq Listing..
02.8.202314:35EDGAR2Form 8-K - Current report
02.8.202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202313:00BWGlycoMimetics Reports Highlights and Financial Results for..
19.7.202313:00BWGlycoMimetics to Report Second Quarter 2023 Financial..
26.6.202314:00BWGlycoMimetics Announces Its Addition to the Russell..
15.6.202314:00BWGlycoMimetics Announces U.S. Food and Drug Administration..
31.5.202313:00BWGlycoMimetics to Participate in Upcoming Jefferies 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock